Chinese Consensus on the Clinical Application of Hepatobiliary Magnetic Resonance Imaging Contrast Agent: Gadoxetic Acid Disodium
Sheng Xiang Rao,Jin Wang,Jian Wang,Xin Qing Jiang,Li Ling Long,Zi Ping Li,Zhen Lin Li,Wen Shen,Xin Ming Zhao,Dao Yu Hu,Hui Mao Zhang,Lin Zhang,Yi Huan,Chang Hong Liang,Bin Song,Meng Su Zeng
DOI: https://doi.org/10.1111/1751-2980.12707
2019-01-01
Journal of Digestive Diseases
Abstract:Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) helps improve the ability of detection and diagnosis of focal hepatic lesions, especially for evaluating smaller lesions (<1 cm in diameter) and the diseases of the biliary system. MRI-based function tests with Gd-EOB-DTPA have gained immense popularity in recent years as it can be integrated into clinical setup with a higher temporal and spatial resolution and without ionizing radiation. Gd-EOB-DTPA has been in use since 2011 in China. However, only a few domestic hospitals have implemented a full-fledged application of Gd-EOB-DTPA. Moreover, most of these hospitals are still in the primary period of Gd-EOB-DTPA application, with limited experience and lack of unitive consciousness. In this situation, the domestic experts who engaged in the same field developed a consensus based on the recommended target users, optimized scanning scheme and application in the diagnosis of cirrhosis-associated nodules during multistep hepatocarcinogenesis, aiming at providing specifications and guidance for Gd-EOB-DTPA-enhanced hepatic MRI examination and improving the overall diagnostic accuracy of hepatic diseases. The recommendations suggested in this piece of work may help the clinicians in rural areas/small hospitals and those who have newly adopted the use of Gd-EOB-DTPA-enhanced hepatic MRI in routine clinical practice.